Related references
Note: Only part of the references are listed.Pharmaceutical Innovation Gets a Little Help from New Friends
Bernard H. Munos
SCIENCE TRANSLATIONAL MEDICINE (2013)
Antibodies to PCSK9 A Superior Way to Lower LDL Cholesterol?
Kara N. Maxwell et al.
CIRCULATION RESEARCH (2012)
Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates
Maria Frank-Kamenetsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Sequence variations in PCSK9, low LDL, and protection against coronary heart disease
JC Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Mutations in PCSK9 cause autosomal dominant hypercholesterolemia
M Abifadel et al.
NATURE GENETICS (2003)